Final hours! Save up to 50% OFF InvestingProCLAIM SALE

German coronavirus deaths hit new high as lockdown starts

Published 2020-12-16, 01:59 a/m
© Reuters. A musician plays his mobile piano at a pedestrian zone in Konstanz
PFE
-

BERLIN (Reuters) - Germany entered a strict lockdown on Wednesday in an attempt to bring soaring coronavirus cases under control as the number of registered deaths from COVID-19 jumped by 952, the highest daily increase yet.

The previous record daily death toll was 598 on Friday. However, the figures reported on Wednesday are not exactly comparable to previous days because they were inflated as a result of a technical problem in one state, according to the Robert Koch Institute for infectious diseases, which collects the numbers.

Fears that the pandemic is spiralling out of control in Germany prompted Chancellor Angela Merkel and the 16 state governors to announce on Sunday a tough lockdown until Jan. 10 at the earliest.

Shops and schools will stay shut from Wednesday in a pre-Christmas tightening of restrictions following a partial lockdown in November, which closed bars and restaurants but failed to contain a second wave of the pandemic.

Germany was more successful than many European countries in keeping the coronavirus under control in the first wave in the spring but the situation looks very different now.

The Robert Koch Institute put the number of confirmed coronavirus cases at 1,379,238, an increase of 27,728. The total death toll in Germany is 23,427.

The 7-day incidence of cases ticked up to 180 per 100,000 people from 174 on Tuesday.

Merkel told lawmakers on Tuesday she was worried by the coronavirus trend and warned them that January and February would be very tough months.

Germans are waiting for regulatory approval for a vaccine partly developed in Germany even as other countries, including Britain and the United States, are rolling it out.

© Reuters. A musician plays his mobile piano at a pedestrian zone in Konstanz

Health Minister Jens Spahn has said Germany should start giving coronavirus shots 24 to 72 hours after the vaccine by BioNTech and Pfizer (NYSE:PFE) gets EU approval and could begin as soon as Christmas. European authorities are expected to approve the vaccine next week.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.